SCAN-COV-HUS: Impact of the CT Scan in Patients With Suspected Covid-19

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05079191
Collaborator
(none)
2,000
1
18
111.3

Study Details

Study Description

Brief Summary

The diagnostic performance of the scanner in the indication of suspected Covid-19 is not yet well known, especially in comparison with the results of RT-PCR.

The potential use of the scanner as a tool for quantifying the severity of Covid-19 disease is not yet well established, especially the variations between readers or between measurement techniques.

The impact of the scanner in predicting the fate of patients with confirmed Covid-19 is not yet known.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Diagnostic Performance and Predictive Impact of the CT Scan in Patients With Suspected Covid-19
    Actual Study Start Date :
    Jun 1, 2020
    Anticipated Primary Completion Date :
    Nov 1, 2021
    Anticipated Study Completion Date :
    Nov 30, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective study of the chest scanner in suspected Covid-19 [Files analysed retrospectively from March 01, 2020 to April 29, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All

    Inclusion criteria

    • Adult patient (≥18 years old)

    • Patient admitted to Strasbourg University Hospitals for suspicion of Covid-19, between 03/01/2020 and 04/29/2020

    • Availability of at least one chest CT scan during hospitalization

    • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

    Non-inclusion criteria

    • Patient who expressed his opposition to participating in the study

    • Patient under legal protection

    • Patient under guardianship or guardianship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de Radiologie B - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05079191
    Other Study ID Numbers:
    • 7844
    First Posted:
    Oct 15, 2021
    Last Update Posted:
    Nov 3, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 3, 2021